US Patent 8343501 Bispecific EGFR/IGFIR binding molecules
Patent 8343501 was granted and assigned to Bristol-Myers Squibb on January, 2013 by the United States Patent and Trademark Office.
All edits
Edits on 9 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 21 Aug, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 29 Nov, 2023
Golden AI
Edits made to:
Article (+518 characters)
Article
Patent abstract
The present invention relates to bispecific molecules comprising an EGFR binding domain and a distinct IGFIR binding domain for use in diagnostic, research and therapeutic applications. The invention further relates to cells comprising such proteins, polynucleotide encoding such proteins or fragments thereof, and vectors comprising the polynucleotides encoding the innovative proteins. Exemplary bispecific molecules include antibody-like protein dimers based on the tenth fibronectin type III domain.
Edits on 14 Jun, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08343501 Bispecific EGFR/IGFIR binding molecules US Patent 8343501 Bispecific EGFR/IGFIR binding molecules
Infobox
Patent Number
0834350100
Patent Number
834350100
Edits on 3 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083435010
Date of Patent
January 1, 2013
0Patent Application Number
126252170
Date Filed
November 24, 2009
0Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
083435010
Date of Patent
January 1, 2013
0Patent Application Number
126252170
Date Filed
November 24, 2009
0Patent Primary Examiner
Edits on 15 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 08343501 Bispecific EGFR/IGFIR binding molecules
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
08343501
Date of patent
January 1, 2013
Patent application number
12625217
Date Filed
November 24, 2009
Patent primary examiner
Find more entities like US Patent 8343501 Bispecific EGFR/IGFIR binding molecules
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.